Population Pharmacokinetics of Revefenacin in Patients with Chronic Obstructive Pulmonary Disease

BACKGROUND AND OBJECTIVES: Revefenacin is a lung-selective, long-acting muscarinic antagonist indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease. The objectives of this analysis were to evaluate the pharmacokinetics of revefenacin and its major metabolite...

Descripción completa

Detalles Bibliográficos
Autores principales: Lo, Arthur, Borin, Marie T., Bourdet, David L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7932972/
https://www.ncbi.nlm.nih.gov/pubmed/33124005
http://dx.doi.org/10.1007/s40262-020-00938-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7932972/
https://www.ncbi.nlm.nih.gov/pubmed/33124005
http://dx.doi.org/10.1007/s40262-020-00938-3

Ejemplares similares